Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/01/2010 | EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome |
12/01/2010 | EP2256201A2 Modulation of eIF4E expression |
12/01/2010 | EP2256200A2 Modulation of eIF4E expression |
12/01/2010 | EP2256199A1 Therapeutic uses of BR43X2 soluble receptors |
12/01/2010 | EP2256198A1 Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases |
12/01/2010 | EP2256197A1 Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases |
12/01/2010 | EP2256196A1 Method for treating a sample that contains biomolecules |
12/01/2010 | EP2256195A1 Nucleic acid purification method |
12/01/2010 | EP2256194A1 Flocculent yeast and method for production thereof |
12/01/2010 | EP2256193A1 Identification of hypertension susceptibility gene group |
12/01/2010 | EP2256192A1 Thermotolerant catalase |
12/01/2010 | EP2256191A1 Cyclic single-stranded nucleic acid complex and method for producing the same |
12/01/2010 | EP2256190A1 Method of diagnosing risk of myocardial infarction |
12/01/2010 | EP2256189A1 Process for producing a plant storage organ in which a GLP-1 derivative recombinant protein is highly produced. |
12/01/2010 | EP2256188A1 Method for increasing enzymatic reactivity |
12/01/2010 | EP2256187A1 Hepatocyte lineage cells derived from pluripotent stem cells |
12/01/2010 | EP2256186A1 Myocardial grafts and cellular compositions |
12/01/2010 | EP2256185A1 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
12/01/2010 | EP2256135A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor |
12/01/2010 | EP2256134A1 IgG Fc fragment for a drug carrier and method for the preparation thereof |
12/01/2010 | EP2256133A1 Bioconjugation of macromolecules |
12/01/2010 | EP2255832A2 IFBM's to promote attachment of target analytes |
12/01/2010 | EP2255787A1 Synthetic glycolipid-containing liposomes |
12/01/2010 | EP2255007A1 Fermentative production of isobutanol using yeast |
12/01/2010 | EP2255006A1 Process for producing tomato plants with long-life characteristics |
12/01/2010 | EP2255005A2 Use of synthetic scaffolds for the production of biosynthetic pathway products |
12/01/2010 | EP2255004A2 Genetically transformed microorganism for biomass fermentation |
12/01/2010 | EP2255003A2 Drought and heat tolerance in plants |
12/01/2010 | EP2255002A2 Method to inhibit ribonuclease dicer, ribonuclease dicer inhibitor, and use of rna aptamers as ribonuclease dicer inhibitors |
12/01/2010 | EP2255001A2 Method of nucleic acid recombination |
12/01/2010 | EP2255000A1 Hydrazine-modified matrices, their use in methods for isolating biomolecules |
12/01/2010 | EP2254999A2 Methods and devices for producing biomolecules |
12/01/2010 | EP2254998A1 Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
12/01/2010 | EP2254995A1 Producing dicarboxylic acids using polyketide synthases |
12/01/2010 | EP2254994A1 Compositions and methods for amino acid biosynthesis |
12/01/2010 | EP2254993A1 Protein nanocarriers, process for obtaining them and applications |
12/01/2010 | EP2254911A1 HUMANIZED ANTI-C5aR ANTIBODIES |
12/01/2010 | EP2254910A1 Use of substances for sensitization of tumor cells to radiation and/or chemotherapy |
12/01/2010 | EP2254909A1 NON-AGGREGATING HUMAN Vh DOMAINS |
12/01/2010 | EP2254904A2 Oligopeptidic compounds and uses thereof |
12/01/2010 | EP2254903A2 Escherichia coli immunogens with improved solubility |
12/01/2010 | EP2254554A1 Sugar glassified virus like particles (vlps) |
12/01/2010 | EP2126074B1 Use of acetals for the isolation of nucleic acids |
12/01/2010 | EP2118280B1 Selection and enrichment of proteins using in vitro compartmentalization |
12/01/2010 | EP2021485B1 Pseudotransposons and recombinant hyperactive transposition systems, derived from the mos-1 transposon |
12/01/2010 | EP1957644B1 Enzymatic encoding methods for efficient synthesis of large libraries |
12/01/2010 | EP1935981B1 Process for producing recombinant protein |
12/01/2010 | EP1930428B1 transformed yeast host cells AND METHOD OF PRODUCING FOREIGN PROTEIN |
12/01/2010 | EP1915453B1 Marker-free plant transformation |
12/01/2010 | EP1869071B1 Tnf-alpha binding polypeptide, uses thereof and methods employing it |
12/01/2010 | EP1831378B1 Sugarcane plants with an increased storage carbohydrate content |
12/01/2010 | EP1808487B1 Method using lactic acid bacterial strain |
12/01/2010 | EP1739174B1 Mutated glucose dehydrogenase |
12/01/2010 | EP1652928B1 Plant producing hyaluronic acid |
12/01/2010 | EP1626088B1 Method of measuring glycolated hemoglobin a1c, enzyme to be used therefor and process for producing the same |
12/01/2010 | EP1625210B1 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
12/01/2010 | EP1589106B1 Adiponectin receptor and gene coding for the same |
12/01/2010 | EP1583832B1 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing |
12/01/2010 | EP1572077B1 Uses of monoclonal antibody 8h9 |
12/01/2010 | EP1561807B1 Method of degrading hardly degradable protein |
12/01/2010 | EP1546316B1 Mutant e. coli appa phytase enzymes and natural variants thereof, nucleic acids encoding such phytase enzymes, vectors and host cells incorporating same and methods of making and using same |
12/01/2010 | EP1536004B1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
12/01/2010 | EP1483392B1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
12/01/2010 | EP1449850B1 Human cdr-grafted antibodies and antibody fragments thereof |
12/01/2010 | EP1434800B1 Immunoglobulin having particular framework scaffold and methods of making and using |
12/01/2010 | EP1427441B1 COMPOSITE SUPERIMMUNOGEN FOR BI-FUNCTIONAL VACCINE Tat-gp160 FOR USE IN THE TREATMENT OF AIDS |
12/01/2010 | EP1423425B1 Receptor, the use thereof, and mouse antibodies |
12/01/2010 | EP1414996B1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
12/01/2010 | EP1414861B1 Humanized antibodies against icam-1, their production and uses |
12/01/2010 | EP1373301B1 Reducing the immunogenicity of fusion proteins |
12/01/2010 | EP1255868B1 Altered recombinases for genome modification |
12/01/2010 | EP1244790B1 Nucleic acids encoding polypeptides having chips activity |
12/01/2010 | EP1058724B1 Maltogenic alpha-amylase variants |
12/01/2010 | EP1027428B1 Alpha-amylase mutants |
12/01/2010 | CN1923847B Linear valve-coupled two-dimensional separation device and separation matrix and method |
12/01/2010 | CN1918305B Method of detecting nucleic acid and utilization therof |
12/01/2010 | CN1852734B Consensus/ancestral immunogens |
12/01/2010 | CN1824675B Neisserial antigens |
12/01/2010 | CN1809584B Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
12/01/2010 | CN1784493B Modified beta-lactamases and uses thereof |
12/01/2010 | CN1772885B Method of inducing stem cell to differentiate into pancreatic island-like cell and application of pancreatic island-like cell |
12/01/2010 | CN1727362B Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen |
12/01/2010 | CN1721446B Fusion protein and method for preparing same |
12/01/2010 | CN1646154B Albumin-fused anti-angiogenesis peptides |
12/01/2010 | CN1592792B Materials and methods for detection of nucleic acids |
12/01/2010 | CN101903529A SM-protein based secretion engineering |
12/01/2010 | CN101903526A Organic compounds |
12/01/2010 | CN101903525A Down-regulation of gene expression using artificial microRNAs |
12/01/2010 | CN101903524A Pathogen control genes and methods of use in plants |
12/01/2010 | CN101903523A Mammalian expression vector |
12/01/2010 | CN101903522A Succinic acid production in a eukaryotic cell |
12/01/2010 | CN101903521A Elimination of contaminants associated with nucleic acid amplification |
12/01/2010 | CN101903520A Nucleic acid amplification method, and reagent and reagent kit for use in the method |
12/01/2010 | CN101903519A Enhanced protein production in bacillus |
12/01/2010 | CN101903518A Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
12/01/2010 | CN101903403A CD19 binding agents and uses thereof |
12/01/2010 | CN101903399A Clostridial toxin netb |
12/01/2010 | CN101903046A Constructs containing multiple expression cassettes for cancer therapy |
12/01/2010 | CN101901656A Preparation method of magnetic particle with surface modified with isothiocyanato active group |
12/01/2010 | CN101900727A Bovine tuberculosis antibody identifying and detecting test strip prepared by applying Rv3872 novel fusion protein |